MENU

Sergei Grivennikov, PhD

Sergei Grivennikov, PhD
About

Associate Professor

Inflammation, Immunity and Microenvironment Lab

Colorectal and SI Cancer TRDG Member

Research Program

Students and Postdocs who wish to join the lab should contact Sergei Grivennikov directly.

Dmittrieva-Posocco et al, Immunity 2019
Normal wound healing, inflammation and tumorigenesis (simplistic view)
Inflammation in Cancer
Cytokines are important for a cross-talk between inflammatory and tumor cells
There are many different types of inflammation associated with tumorigenesis
Oncogene-driven loss of barrier function and activation of immune cells

 

Education and Training

Educational Background

  • Postdoctoral Training, University of California San Diego. San Diego, CA, 2012
  • PhD, Engelhardt Institute of Molecular Biology, Moscow, Russia, 2004
  • MS, Moscow State University, Moscow, Russia, 2000

Honors & Awards

  • Landon Innovator Award in Tumor Microenvironment, AACR  2014
  • Pew Scholar, Biomedical Sciences  2013
  • Pathway to Independence Award , NIH, K99/R00   2011 
  • Career Development Award, Crohn’s & Colitis Foundation of America   2011  
  • Award for Postdoctoral Fellows, National Institutes of Health   2005  
  • Research Fellowship Award, Crohn’s & Colitis Foundation of America   2007  
Research Profile

Research Program

Research Facility

Inflammation, Immunity and Microenvironment Lab

Research Interests

How immune and inflammatory pathway promote tumor growth and progression

  • Role of cytokines in tumor development
  • Mechanisms of tumor-elicited inflammation
  • Role of inflammatory pathways in normal regeneration and in response to anti-cancer therapies
  • Mouse models of inflammation and cancer

Lab Overview

It has become recently clear that Inflammation plays important roles at different stages of tumor development, including initiation, promotion, malignant conversion, invasion, and metastasis. Immune cells that infiltrate tumors engage in an extensive and dynamic crosstalk with cancer cells and some of the molecular events that mediate this dialog have been revealed. Inflammatory microenvironment is an essential component of all tumors, including some in which a direct causal relationship with inflammation is not yet proven. Importantly, only a minority of all cancers are caused by germline mutations, whereas the vast majority (90%) are linked to somatic mutations or epigenetic changes and environmental factors, including preceding chronic inflammation. Recent studies provided further evidence about the connection between inflammation and cancer, as non-steroid anti-inflammatory drugs such as aspirin, significantly lower the risk of cancer death. Several types of tumor-associated inflammation have been outlined, which either pro- or anti-tumorigenic effect. Given the importance of the functional interaction between immune cells and cancer cells, the outstanding question is what mediates such a cross-talk?

Our research interests are to connect various immune signaling pathways with pathogenesis of inflammation-associated and sporadic cancers, including colon cancer.

Research in the lab utilizes various genetic animal models of immunodeficiency and cancer as well as human tissues, and follows several major directions: 

1. Examine the role of various inflammatory cytokine pathways in regulation of tumor-elicited inflammation tumor growth, invasion and metastasis.
2. Explore the mechanisms of how inflammatory response in the tumors is induced, including potential contribution of microbiota and endogenous factors produced by the host.
3. How manipulations with the strength and specificity of the host inflammatory response may aid in the development of better preventive and therapeutic strategies.

Lab Staff

Reem Ghinnagow, PhD

Postdoctoral Associate

Room: P2111
215-214-3927

Natalia Andreeva

MS Student

Room: P2107
215-214-3927

Elena Ivleva

MS Student

Room: P2107
215-214-3927

Railia Gabbasova, MS

Graduate Student

Room: P2111
215-214-3927

Svetlana Khoziainova

Graduate Student

Room: P2107
215-214-3927

Philip Czyzewicz

Scientific Technician

Room: P2107
215-214-3927

Additional Staff

Former Lab Members

Oxana Dmitrieva, MD
Ralph Francescone, PhD, Postdoctoral Researcher
Wei Guo, BS
Vivi Hou, BS
Paula Mafra (Visiting PhD Student)
David Posocco, BS, Scientific Technician
Ashley Russell, MS
Yi Shao, BS (Visiting Student)
Debora Vendramini, PhD, Visiting Postdoctoral Researcher

Publications

Selected Publications

Dmitrieva-Posocco OS, Dzutsev A, Posocco D, Yuan W, Thovarai V,  Hou V, Mufazalov I, Gunzer M, Shilovskyi I, Khaitov M, Trinchieri G., Waisman A, Grivennikov SI. Cell-type specific responses to interleukin-1 control microbial invasion and tumor elicited inflammation in  colorectal cancer. Immunity. 2019 Jan 15;50(1):166-180.e7. doi: 10.1016/j.immuni.2018.11.015.PMID:30650375

Fatkhullina AR, Peshkova IO, Dzutsev A, Aghayev T, McCulloch JA, Thovarai V, Badger JH, Vats R, Sundd P, Tang HY, Kossenkov AV, Hazen SL, Trinchieri G, Grivennikov SI **, Koltsova EK **. An IL23-IL22 axis regulates intestinal microbial homeostasis to protect from diet-induced atherosclerosis. Immunity. 2018. Oct 25. pii: S1074-7613(18)30426-6. doi: 10.1016/j.immuni.2018.09.011. PMID:30389414, PMCID: PMC6257980, ** equal senior contribution

Ingram JP, Tursi S, Zhang T, Guo W, Yin C, M AW-D, van der Heijden J, Cai KQ, Yamamoto M, Finlay BB, Brodsky IE, Grivennikov SI, Tukel C, Balachandran S. A Nonpyroptotic IFN-gamma-Triggered Cell Death Mechanism in Nonphagocytic Cells Promotes Salmonella Clearance In Vivo. Journal of immunology (Baltimore, Md : 1950), 200(10):3626-34, 2018. PubMed

Vendramini-Costa DB, Francescone R, Posocco D, Hou V, Dmitrieva O, Hensley H, de Carvalho JE, Pilli RA, Grivennikov SI. Anti-inflammatory natural product goniothalamin reduces colitis-associated and sporadic colorectal tumorigenesis. Carcinogenesis, 38(1):51-63, 2017. PMC5219049

Koltsova EK, Grivennikov SI. IMPlicating Mesenchymal Imp1 in Colitis-Associated Cancer. Mol Cancer Res. 2015 Nov;13(11):1452-4. doi: 10.1158/1541-7786.MCR-15-0385. Epub 2015 Oct 9. PubMed

Francescone R, Hou V, Grivennikov SI. Cytokines, IBD, and colitis-associated cancer. Inflamm Bowel Dis. 2015 Feb;21(2):409-18. doi: 10.1097/MIB.0000000000000236. Review. PubMed

Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J, Zhang W, Zhong Z, Sanchez-Lopez E, Wu LW, Taniguchi K, Feng Y, Fearon E, Grivennikov SI, Karin M. Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity. 2014 Dec 18;41(6):1052-63. doi: 10.1016/j.immuni.2014.11.009. Epub 2014 Nov 25. PubMed

Francescone R, Hou V, Grivennikov SI. Microbiome, inflammation, and cancer. Cancer J. 2014 May-Jun;20(3):181-9. PubMed

Koltsova EK, Grivennikov SI. IL-22 gets to the stem of colorectal cancer. Immunity. 2014 May 15;40(5):639-41. doi: 10.1016/j.immuni.2014.04.014. PubMed

Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D, Taniguchi K, Yu GY, Osterreicher CH, Hung KE, Datz C, Feng Y, Fearon ER, Oukka M, Tessarollo L, Coppola V, Yarovinsky F, Cheroutre H, Eckmann L, Trinchieri G, Karin M. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature. 2012 Nov 8;491(7423):254-8. PubMed

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010 Mar 19;140(6):883-99. PubMed

Additional Publications

My NCBI

This Fox Chase professor participates in the Undergraduate Summer Research Fellowship
Learn more about Research Volunteering.

Connect with Fox Chase